Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

EHR-derived Data on Tumor Progression May Predict Survival

Publish date:: September 10, 2019

Key clinical point: Electronic health record data could be used to study clinically relevant survival endpoints.

Major finding: EHR-based PFS data showed moderately high correlation with OS.

Study details: Retrospective analysis of EHR data and outcomes for 30,276 patients diagnosed with advanced NSCLC.

Disclosures: The study was supported by Flatiron Health, a subsidiary of Roche. Dr. Griffiths and multiple coauthors are employees and stockholders of Flatiron Health and/or Roche.

Citation:

Griffith SD et al. JCO Clinical Informatics. 2019 Aug 12. doi: 10.1200/CCI.19.00013.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Lung Cancer

Two different radiation boost strategies reduce local failures in NSCLC,

Rechallenge ‘reasonable’ for some with small-cell lung cancer,

Black patients with ES-SCLC get less chemo but have better survival,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Reduced cancer mortality with Medicaid expansion,